Since 2012, we’ve invested in nearly 20 healthcare companies with a combined enterprise value of £750m.

UK healthcare has evolved into a global pioneer. Innovation continues to transform the sector, creating many routes to growth. And despite the significant challenges posed by talent shortages, funding pressures and policy changes – demand for services has never been greater.

We’ve worked with some of the most ambitious teams in UK healthcare – across sub-sectors including healthcare services, pharma services and MedTech & devices. Helping with opportunities including expanding through organic growth, pursuing buy-and-build strategies, developing new products or entering new overseas markets.

Our current portfolio includes a diverse range of healthcare companies including TMC Pharma Services, EMS Group, Real Digital, Duncan & Todd Group, Kingswood, Connect Health, PAM Group and Ashtons.

Healthcare Sector Report

The first in a series of LDC Sector Reports, our Healthcare Report looks at trends and how the sector is responding to change. We look at how private equity investment can support growth opportunities – from M&A and ESG to technology development. Download the report to find out more.

Download Healthcare Sector Report
Sector-Report-Thumbnail- website (003)
Quote mark

Our partnership with LDC helped us transform the scale of the business, creating a platform to support rapid expansion through acquisition and the impact on our colleagues and clients has been hugely positive.”

Dennis O’Brien,
CEO, Lucid Group

Speak to our Healthcare Team

Matt Newbold

Investment Director

West Midlands

+44 (0)121 237 6500

Christian Bruning

Partner, Co-Head of London


+44 (0)207 758 3720

Josh Wachman

Investment Manager


+44 (0)207 758 3683

Grant Goodwin

Investment Director

North West

+44 (0)161 831 1740

Jennifer Hatton

Investment Executive

North West

+44 (0)161 831 1723